None (PHAT) SEC News Oct. 30, 2025, 00:00 UTC (13% Negative) PHATHOM PHARMACEUTICALS, INC. (PHAT) Reports Net Loss for 2025-09-30 Full text
Register to leave comments News bot Nov. 2, 2025, 10:18 a.m. 🏢 None (PHAT) - Form 10-Q Quarterly Report Quarterly financial filing submitted to the SEC 📋 Filing Information 📄 Form Type: 10-Q 📅 Filing Date: 2025-10-30 📊 Period of Report: 2025-09-30 ⏰ Accepted: N/A 📊 Key Financial Metrics (Period-over-Period Comparison) Metric Current Period Previous Period Change ($) Change (%) Trend Net Income/Loss $-259.88M $-200.10M $-59.78M -29.87% 📈 Total Assets $378.32M $240.29M $138.03M +57.44% 📈 Total Liabilities $631.90M $662.82M $-30.93M -4.67% ↘️ Stockholders' Equity $-187.11M $-1.19B $1.00B +84.26% 📈 Operating Income/Loss $-218.05M $-154.06M $-63.99M -41.54% 📈 Gross Profit $21.43M $102.58M $-81.14M -79.11% 📉 R&D Expense $25.50M $25.29M $212.00K +0.84% ↗️ SG&A Expense $213.98M $231.35M $-17.36M -7.51% 📈 Revenues $25.59M $117.53M $-91.94M -78.23% 📉 Earningspersharebasic $-4.29 $-2.76 $-1.53 -55.43% 📉 Earningspersharediluted $-4.29 $-2.76 $-1.53 -55.43% 📉 Costofrevenue $4.16M $14.95M $-10.79M -72.19% 📉 📈 Financial Trend Analysis 🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities 📎 View Full 10-Q Filing on SEC.gov Access the complete official filing document
🏢 None (PHAT) - Form 10-Q Quarterly Report
📋 Filing Information
Key Financial Metrics (Period-over-Period Comparison)
Financial Trend Analysis
🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities
📎 View Full 10-Q Filing on SEC.gov
Access the complete official filing document